Task B03: In Vitro Assessments for Antimicrobial Activity Against Respiratory Viruses

任务 B03：针对呼吸道病毒的抗菌活性的体外评估

• 批准号: 10212520
• 负责人: BRETT HURST
• 金额: $ 31.93万
• 依托单位: UTAH STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-06-26 至 2021-06-25
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10212520
• 关键词: 2019-nCoV; Advanced Development; Antiviral Agents; Biological Assay; COVID-19; Cell Line; Contracts; In Vitro; Maintenance; Viral; antimicrobial; in vitro testing; novel coronavirus; respiratory virus; therapeutic development; virus development

This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.

该合同提供了潜在的抗病毒药物的体外测试，病毒储备和细胞系的维持，以及相关检测的开发。